Andrzej Skladanowski Selected Research

Andrzej Skladanowski Research Topics

16	Neoplasms (Cancer) 12/2017 - 05/2002
3	Leukemia 12/2015 - 09/2005
3	Adenocarcinoma of Lung 12/2015 - 10/2009
3	Carcinoma (Carcinomatosis) 05/2010 - 01/2002
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2007
1	Lung Neoplasms (Lung Cancer) 06/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2005
1	Colonic Neoplasms (Colon Cancer) 10/2004

8	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 01/2002
5	Antineoplastic Agents (Antineoplastics)IBA 01/2014 - 06/2007
4	C 1305IBA 05/2010 - 07/2004
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2010 - 01/2003
2	TuftsinIBA 12/2015 - 04/2011
2	Topoisomerase II InhibitorsIBA 05/2010 - 08/2003
2	Caffeine (No Doz)FDA LinkGeneric 10/2009 - 08/2008
2	7-hydroxystaurosporine (UCN 01)IBA 09/2007 - 01/2002
1	AnthraquinonesIBA 12/2017
1	AnthracyclinesIBA 12/2017
1	Leucine (L-Leucine)FDA Link 12/2015
1	Isoleucine (L-Isoleucine)FDA Link 12/2015
1	NU 1025IBA 05/2010
1	AcridinesIBA 05/2009
1	Phosphotransferases (Kinase)IBA 08/2008
1	CarcinogensIBA 08/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2008
1	Interleukin-8 (Interleukin 8)IBA 08/2008
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 09/2007
1	Cisplatin (Platino)FDA LinkGeneric 09/2007
1	WortmanninIBA 09/2007
1	ChalconesIBA 05/2007
1	SurvivinIBA 12/2005
1	Vincristine (Oncovin)FDA LinkGeneric 09/2005
1	C 1311IBA 03/2005
1	RNA (Ribonucleic Acid)IBA 05/2002
1	Etoposide (VP 16)FDA LinkGeneric 01/2002
1	Topoisomerase InhibitorsIBA 01/2002
1	CamptothecinIBA 01/2002